Check out our most popular compounded medications! Get Started
Our Pyrazinamide 100 mg/ml Oral Liquid is a specially crafted medication designed for oral use, ensuring a precise and consistent dose of pyrazinamide in each administration. This liquid formulation is particularly beneficial for patients who experience difficulty swallowing tablets or capsules, including pediatric and geriatric patients. Pyrazinamide, the active ingredient, is an essential medication in the treatment of tuberculosis (TB), working effectively as part of a combination therapy to combat this serious infectious disease. The liquid form allows for flexible dosing, tailored to the specific needs of the individual, and promotes better patient compliance in the management of tuberculosis.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Pyrazinamide 100 mg/ml Oral Liquid is a specially compounded medication designed for oral use, providing a precise 100 milligrams of pyrazinamide per milliliter of liquid. This formulation is particularly beneficial for patients who have difficulty swallowing tablets or capsules, such as children and the elderly, or for those with conditions that impair their ability to ingest solid forms of medication. The liquid form ensures ease of administration and allows for flexible dosing, which can be adjusted according to the specific needs of the patient.
Pyrazinamide, the active ingredient in this formulation, is an essential medication used in the treatment of tuberculosis (TB). It is typically used in combination with other antitubercular drugs to effectively combat the Mycobacterium tuberculosis bacteria. Pyrazinamide works by disrupting the bacterial cell membrane metabolism and energy production, leading to the death of the bacteria.
For prescribers, it is important to note that the dosing of Pyrazinamide 100 mg/ml Oral Liquid should be based on the patient's weight and the severity of the disease. Regular monitoring of liver function tests is recommended due to the potential hepatotoxicity associated with pyrazinamide. Additionally, patients should be counseled on the importance of adherence to the full course of therapy to prevent the development of drug-resistant TB strains.
Patients should be instructed on how to measure and take the correct dose of Pyrazinamide 100 mg/ml Oral Liquid, and they should be made aware of potential side effects, which may include liver toxicity, nausea, vomiting, and arthralgia. It is also important for patients to understand that while the liquid formulation may be more palatable or easier to swallow, the efficacy and potential side effects remain consistent with those of the solid dosage forms of pyrazinamide.
If you have any questions or require further information about Pyrazinamide 100 mg/ml Oral Liquid, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing support and guidance to ensure the safe and appropriate use of this medication.
Pyrazinamide is an antitubercular medication used in combination with other drugs to treat tuberculosis (TB). When taking pyrazinamide, it is important to be aware of potential drug interactions that may affect the efficacy of the treatment or increase the risk of adverse effects. Patients should inform their healthcare providers of all medications, supplements, and herbal products they are currently taking before starting pyrazinamide therapy.
One significant interaction is with allopurinol, a medication used to treat gout. Allopurinol can increase the levels of pyrazinamide in the blood, potentially leading to toxicity. Patients on allopurinol may require dosage adjustments or close monitoring when starting pyrazinamide. Similarly, probenecid, used to treat gout and to increase blood levels of certain antibiotics, can also increase pyrazinamide levels and the risk of toxicity.
Pyrazinamide is a hepatotoxic drug, and its use with other hepatotoxic drugs (such as acetaminophen, especially at higher doses, or certain antiretrovirals) should be approached with caution. Liver function tests should be monitored closely in patients receiving such combinations. Additionally, pyrazinamide can antagonize the effects of the antitubercular drug isoniazid. When used together, these drugs should be carefully balanced to ensure therapeutic efficacy while minimizing the risk of liver damage.
Patients with diabetes should be aware that pyrazinamide can interfere with the effectiveness of insulin and oral hypoglycemic agents, potentially leading to poor blood glucose control. Dosage adjustments of diabetes medications may be necessary when starting pyrazinamide treatment. Furthermore, pyrazinamide may increase uric acid levels in the blood, which can exacerbate gout. Patients with a history of gout should be closely monitored, and adjustments to their gout medication may be required.
It is also important to note that pyrazinamide can affect the metabolism of certain drugs by altering hepatic enzyme activity. This can lead to either increased or decreased levels of co-administered drugs, necessitating careful monitoring and possible dosage adjustments. For example, the metabolism of theophylline, used to treat asthma and COPD, can be affected by pyrazinamide, potentially requiring dose adjustments to maintain therapeutic levels.
Lastly, pyrazinamide is contraindicated in patients with severe hepatic damage or acute gout. It should be used with caution in individuals with pre-existing liver conditions, alcoholism, or in those who are pregnant or breastfeeding, as the effects on the fetus and infant are not well established.
Due to the complexity of drug interactions with pyrazinamide, it is crucial for healthcare providers to conduct a thorough medication review prior to initiating treatment. Patients should be counseled on the importance of adhering to prescribed regimens and reporting any side effects or new medications to their healthcare provider. If you have any questions or concerns regarding the use of pyrazinamide 100 mg/ml oral liquid or its interactions with other medications, please reach out to us at Bayview Pharmacy for further assistance.
Pyrazinamide is an antimycobacterial agent that is used as part of the combination therapy for tuberculosis (TB). The active ingredient, pyrazinamide, works by disrupting the growth of the bacteria that cause tuberculosis. It is believed to target the mycobacterial cell membrane and interfere with essential biosynthetic processes, ultimately leading to the death of the bacteria. Pyrazinamide is a prodrug, which means it is converted into its active form, pyrazinoic acid, by the bacterial enzyme pyrazinamidase. Once converted, pyrazinoic acid lowers the pH within the mycobacterium to a level that is inhospitable for its growth and survival.
The 100 mg/ml oral liquid formulation of pyrazinamide provides a precise dosage that can be easily measured and administered, which is particularly beneficial for patients who have difficulty swallowing pills, such as children and the elderly. Additionally, the liquid formulation allows for dose flexibility, which is important for tailoring the treatment to the patient's specific needs, based on their weight and the severity of the infection.
When treating tuberculosis, pyrazinamide is typically used in combination with other TB medications, such as isoniazid, rifampin, and ethambutol. Pyrazinamide is particularly useful during the initial phase of TB treatment, helping to reduce the duration of therapy when compared to regimens without pyrazinamide. It is important to note that the use of pyrazinamide should be guided by susceptibility testing and should be part of a comprehensive treatment plan developed by a healthcare professional experienced in the management of TB.
For patients and prescribers considering the use of this pyrazinamide 100 mg/ml oral liquid formulation, it is essential to understand the importance of adherence to the prescribed regimen and the potential side effects, which may include liver toxicity, gastrointestinal upset, and hypersensitivity reactions. Regular monitoring of liver function tests is recommended during treatment with pyrazinamide. If you have any questions or concerns about this formulation or its use in treating tuberculosis, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide the necessary support and guidance to ensure appropriate treatment.
Pyrazinamide 100 mg/ml Oral Liquid is commonly prescribed as part of the treatment for tuberculosis (TB). It is often used in combination with other TB medications to effectively combat the infection caused by Mycobacterium tuberculosis bacteria.
This medication should be taken exactly as prescribed by your healthcare provider. It is typically administered orally with or without food. If stomach upset occurs, taking it with food may help. Shake the bottle well before each dose to ensure the medication is properly mixed.
Yes, Pyrazinamide Oral Liquid is suitable for children, particularly when providing accurate dosing is critical or when a child may have difficulty swallowing tablets or capsules. Your healthcare provider will determine the appropriate dose for the pediatric patient based on weight and clinical condition.
Yes, this formulation can be especially beneficial for elderly patients who may face difficulties swallowing solid dosage forms, such as tablets. The liquid form allows for easier ingestion and dosage flexibility for various needs.
If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for the missed one.
As with all medications, Pyrazinamide Oral Liquid may cause side effects. Common side effects may include joint pain, loss of appetite, nausea, or a mild rash. Contact your healthcare provider if you experience any serious side effects or if mild side effects persist or worsen.
This liquid medication should be stored in a cool, dry place, away from direct sunlight and out of reach of children. Make sure to keep the bottle tightly closed when not in use. Follow any specific storage instructions provided by your pharmacist or the product labeling.
Many liquid medications can be mixed with certain foods or beverages to enhance palatability. However, you should consult with your healthcare provider or pharmacist to ensure that doing so will not affect the medication's effectiveness.
If you suspect an overdose of Pyrazinamide Oral Liquid, you should seek emergency medical attention immediately. Overdose symptoms may include nausea, vomiting, severe fatigue, yellowing of the skin or eyes, or dark urine.
Yes, Pyrazinamide can cause liver problems and increase uric acid levels, leading to gout-like symptoms. Regular monitoring of liver function and uric acid levels by your healthcare provider is recommended during treatment with this medication.
Alcohol consumption should generally be avoided while taking Pyrazinamide since it can increase the risk of liver damage and may also contribute to other side effects. Discuss with your healthcare provider any concerns you may have about alcohol and your treatment regimen.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
